Pilot trial of LET optimized IMPT for pediatric patients with ependymoma
MD Anderson Study Status
This phase I trial studies the side effects of linear energy transfer (LET) optimized image modulated proton therapy (IMPT) in treating pediatric patients with ependymoma. Radiation therapy such as LET optimized IMPT, uses proton beams to kill tumor cells and shrink tumors without damaging surrounding normal tissues.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Anaplastic Ependymoma, Ependymoma
For general questions about clinical trials:
Help us #endcancer
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.